ERS updated position statement on novel nicotine and tobacco products

The statement maintains that the European Respiratory Society (ERS) cannot recommend "harm reduction" as a population-based strategy to reduce smoking and aid quitting, outlining that there is not sufficient evidence to support the tobacco industry's claim that the use of such products can indeed help to reduce tobacco harms, and that such claims are simply exploited by the tobacco industry for financial gain.

Read the statement in full | Order your print copy of Supporting Tobacco Cessation